Quidel To Pay $17M To Settle Inverness Patent Dispute

Law360, New York (April 27, 2005, 12:00 AM EDT) -- Medical device maker Quidel will pay rival Inverness Medical Innovations, Inc. $17 million plus royalties under a cross-licensing agreement to settle their far-reaching patent dispute over diagnostic tests.

Under the agreement, Quidel will take a license to Inverness patents that cover lateral flow technology for all diagnostic products other than for cardiology testing and for over-the-counter women's health products.

Inverness will receive a net payment of $17 million and net future royalties from Quidel at 8.5% of net revenues from products utilizing the licensed patents, the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.